These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


477 related items for PubMed ID: 15262141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE, Potish RA, Argenta PA, Judson PL.
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [Abstract] [Full Text] [Related]

  • 3. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):786-96. PubMed ID: 14967435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F, Terzibachian JJ, Aouar Z, Govyadovskiy A, Lassabe C.
    Gynecol Obstet Fertil; 2008 Jun 01; 36(6):628-35. PubMed ID: 18538624
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM, Webster KD, Belinson JL, Rybicki LA, Kennedy AW, Markman M.
    Gynecol Oncol; 2000 Aug 01; 78(2):221-7. PubMed ID: 10926807
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A clinical analysis of 153 uterine sarcomas].
    Bai P, Sun J, Chao H.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar 01; 32(3):163-7. PubMed ID: 9596892
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S, Gaffney DK.
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec 01; 25(6):761-72. PubMed ID: 21783424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A.
    Gynecol Oncol; 2008 Oct 01; 111(1):74-81. PubMed ID: 18657852
    [Abstract] [Full Text] [Related]

  • 17. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
    Coquard R, Romestaing P, Ardiet JM, Mornex F, Sentenac I, Gérard JP.
    Bull Cancer; 1997 Jun 01; 84(6):625-9. PubMed ID: 9295866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Results of primary and adjuvant radiotherapy in the treatment of mixed Müllerian tumors of the corpus uteri.
    Knocke TH, Weitmann HD, Kucera H, Kölbl H, Pokrajac B, Pötter R.
    Gynecol Oncol; 1999 Jun 01; 73(3):389-95. PubMed ID: 10366465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.